ATE389719T1 - Behandlungsverfahren mit wisp-polypeptiden - Google Patents

Behandlungsverfahren mit wisp-polypeptiden

Info

Publication number
ATE389719T1
ATE389719T1 AT01987803T AT01987803T ATE389719T1 AT E389719 T1 ATE389719 T1 AT E389719T1 AT 01987803 T AT01987803 T AT 01987803T AT 01987803 T AT01987803 T AT 01987803T AT E389719 T1 ATE389719 T1 AT E389719T1
Authority
AT
Austria
Prior art keywords
administration
cartilage
treatment
injury
repair
Prior art date
Application number
AT01987803T
Other languages
English (en)
Inventor
Luc Desnoyer
Ellen Filvaroff
Diane Pennica
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE389719T1 publication Critical patent/ATE389719T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT01987803T 2000-10-16 2001-10-12 Behandlungsverfahren mit wisp-polypeptiden ATE389719T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24122200P 2000-10-16 2000-10-16

Publications (1)

Publication Number Publication Date
ATE389719T1 true ATE389719T1 (de) 2008-04-15

Family

ID=22909763

Family Applications (3)

Application Number Title Priority Date Filing Date
AT01987803T ATE389719T1 (de) 2000-10-16 2001-10-12 Behandlungsverfahren mit wisp-polypeptiden
AT10000199T ATE544855T1 (de) 2000-10-16 2001-10-12 Wisp polypeptide, und deren therapeutische anwendungen
AT08001040T ATE456655T1 (de) 2000-10-16 2001-10-12 Behandlungsverfahren unter verwendung von wisp- polypeptiden

Family Applications After (2)

Application Number Title Priority Date Filing Date
AT10000199T ATE544855T1 (de) 2000-10-16 2001-10-12 Wisp polypeptide, und deren therapeutische anwendungen
AT08001040T ATE456655T1 (de) 2000-10-16 2001-10-12 Behandlungsverfahren unter verwendung von wisp- polypeptiden

Country Status (10)

Country Link
US (2) US7687460B2 (de)
EP (3) EP2180053B1 (de)
JP (1) JP4202128B2 (de)
AT (3) ATE389719T1 (de)
AU (2) AU2002224377B2 (de)
CA (1) CA2425145C (de)
DE (2) DE60141236D1 (de)
ES (3) ES2338492T3 (de)
IL (3) IL155279A0 (de)
WO (1) WO2002033085A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002224377B2 (en) * 2000-10-16 2007-07-19 Genentech, Inc. Methods of Treatment Using WISP Polypeptides
WO2005025603A2 (en) * 2003-09-11 2005-03-24 Genentech, Inc. Methods of using wisp antagonists
SE0401069D0 (sv) * 2004-04-26 2004-04-26 Anamar Medical Ab Use of Compounds for the Treatment of Diseases and Conditions
JP2009540826A (ja) * 2006-06-20 2009-11-26 ジェンザイム・コーポレーション 軟骨細胞増幅のための無血清培地およびその使用
AU2008246125B2 (en) 2007-04-26 2013-01-24 Genera Istrazivanja D.O.O. Blood biomarkers for bone fracture and cartilage injury
AU2009234338B2 (en) 2008-01-18 2014-07-24 Burnham Institute For Medical Research Methods and compositions related to internalizing RGD peptides
CN102869384B (zh) 2009-06-22 2016-01-13 伯纳姆医学研究所 使用带有c-端元件的肽和蛋白质的方法和组合物
JP5602850B2 (ja) 2009-07-14 2014-10-08 ザ スクリプス リサーチ インスティテュート 間葉幹細胞分化
EP2671079B1 (de) * 2011-01-31 2018-12-26 Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. Snx9 als neue biomarker für chronische entzündungen und zugehörige immunosuppression sowie ein neuer regulator der t-zell-rezeptorexpression und funktion
RU2014133069A (ru) 2012-02-11 2016-04-10 Дженентек, Инк. Транслокации r-спондина и способы с их использованием
US9301971B2 (en) 2013-03-08 2016-04-05 Novartis Ag Peptides and compositions for treatment of joint damage
UY35368A (es) 2013-03-08 2014-10-31 Irm Llc Péptidos y composiciones para el tratamiento de daño articular
WO2017123951A1 (en) * 2016-01-14 2017-07-20 Spinacyte, Llc Cellular blend for the regeneration of chondrocytes or cartilage type cells
US10828347B2 (en) * 2016-06-02 2020-11-10 Societe Des Produits Nestle S.A. Methods for treating sarcopenia and muscle injury
TW202027794A (zh) 2018-10-03 2020-08-01 瑞士商諾華公司 血管生成素樣３多肽之持續遞送
KR102167443B1 (ko) * 2019-03-25 2020-10-19 주식회사 카티프라임 체외 골관절염 모델 및 이를 이용한 골관절염 치료제 스크리닝 방법
CN111700881B (zh) * 2020-07-02 2021-05-18 四川大学 Wnt蛋白＼ZIF-8纳米复合体、其制备方法及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364839A (en) 1990-06-18 1994-11-15 Genetics Institute, Inc. Osteoinductive pharmaceutical formulations
US5206023A (en) 1991-01-31 1993-04-27 Robert F. Shaw Method and compositions for the treatment and repair of defects or lesions in cartilage
US5408040A (en) 1991-08-30 1995-04-18 University Of South Florida Connective tissue growth factor(CTGF)
EP0736034A4 (de) 1993-12-22 1999-02-03 Merck & Co Inc Den wnt-x wachstumsfaktor kodierende dns
US5444047A (en) 1994-06-16 1995-08-22 Dipasquale; Gene Treatment of arthritic and post-surgical orthopedic conditions with Insulin-like Growth Factor-I
WO2000053753A2 (en) * 1999-03-08 2000-09-14 Genentech, Inc. Promotion or inhibition of angiogenesis and cardiovascularization
EP0990000B1 (de) 1996-11-08 2005-07-27 Human Genome Sciences, Inc. Bindegewebe-wachstumsfaktor 3.
EP0996724A1 (de) * 1997-06-19 2000-05-03 Incyte Pharmaceuticals, Inc. Wachstumsfaktorähnliches portein-kodierendes polynukleotid
US20020192209A1 (en) * 1997-09-17 2002-12-19 Genentech, Inc. Methods and compositions for inhibiting neoplastic cell growth
IL135704A (en) * 1997-10-29 2008-04-13 Genentech Inc Method for the diagnosis of cancerous growth of cells by identifying the secreted polypeptide WISP-1 affected by WNT-1
WO1999062927A1 (en) * 1998-06-05 1999-12-09 Human Genome Sciences, Inc. Connective tissue growth factor-4
KR100342045B1 (ko) * 1999-04-16 2002-06-27 김순택 2차전지
WO2001007085A1 (en) 1999-07-23 2001-02-01 Case Western Reserve University Novel methods and reagents useful in the treatment of osteoarthritis
US20020063763A1 (en) * 2000-11-29 2002-05-30 Mantell David Allen Apparatus and method for removing air bubbles from an ink jet printhead
GB9930768D0 (en) * 1999-12-29 2000-02-16 Pfizer Ltd Composition
US6812339B1 (en) * 2000-09-08 2004-11-02 Applera Corporation Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
AU2002224377B2 (en) * 2000-10-16 2007-07-19 Genentech, Inc. Methods of Treatment Using WISP Polypeptides

Also Published As

Publication number Publication date
ES2381935T3 (es) 2012-06-01
US20100093628A1 (en) 2010-04-15
AU2002224377B8 (en) 2002-04-29
ATE544855T1 (de) 2012-02-15
DE60133301D1 (de) 2008-04-30
AU2002224377B2 (en) 2007-07-19
CA2425145A1 (en) 2002-04-25
EP2180053B1 (de) 2012-02-08
EP1927659B1 (de) 2010-01-27
CA2425145C (en) 2011-08-30
ES2304401T3 (es) 2008-10-16
ES2338492T3 (es) 2010-05-07
EP1927659A1 (de) 2008-06-04
US20050054563A1 (en) 2005-03-10
WO2002033085A2 (en) 2002-04-25
IL155279A0 (en) 2003-11-23
JP2004534720A (ja) 2004-11-18
EP2180053A3 (de) 2010-11-10
US7687460B2 (en) 2010-03-30
IL155279A (en) 2011-05-31
IL200484A (en) 2012-05-31
ATE456655T1 (de) 2010-02-15
DE60133301T2 (de) 2009-05-14
IL200484A0 (en) 2010-04-29
JP4202128B2 (ja) 2008-12-24
US8138152B2 (en) 2012-03-20
EP1326980B1 (de) 2008-03-19
WO2002033085A9 (en) 2002-07-25
DE60141236D1 (de) 2010-03-18
WO2002033085A3 (en) 2003-04-17
EP1326980A2 (de) 2003-07-16
EP2180053A2 (de) 2010-04-28
AU2437702A (en) 2002-04-29

Similar Documents

Publication Publication Date Title
IL200484A0 (en) Use of wisp polypeptides wisp for the preparation of medicaments
AU4935701A (en) Use of insulin for the treatment of cartilagenous disorders
ATE265529T1 (de) Bmp-10 zusammensetzungen
ATE362766T1 (de) Apolipoprotein a-i agonisten sowie deren verwendung zur behandlung dislipidemischer erkrankungen
DE69729125D1 (de) Troponin untereinheiten und fragmente zur verwendung als inhibitoren der angiogenese
DE69835810D1 (de) Osteogene vorrichtungen und verfahren zu ihrer verwendung zur knochenreparatur
DK1378572T3 (da) BMP-11-sammensætninger
ATE390142T1 (de) Synergistische zusammensetzung zur behandlung von diabetes mellitus
PT807633E (pt) Novas pirimidin-4-onas substituidas em 2,3, e fundidas com heteroarilo em (5,6)
EA200400734A1 (ru) Способ и композиция для потенциирования действия опиатного анальгетика
DE69821793D1 (de) Neuronale verwendungen des bmp-11
ATE453402T1 (de) Verwendung von serp-1 in kombination mit einem immunosuppressor zur behandlung von arthritis
IT1293305B1 (it) Sali di acidi difosfonici e loro impiego farmacologico nel trattamento dell'osteoporosi
SE8902042D0 (sv) Treatment of arthritis
DE69808475D1 (de) Aminosäurederivate zur behandlung von schlaganfall
DK0918455T3 (da) Anvendelse af galanin til reparation af nerveskader
DE69941134D1 (de) Verwendung von R (+)- g(a)-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethanol zur Behandlung von Schlafstörungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1326980

Country of ref document: EP